N/A
Completed N=20
Compass Device CVC Trial
Blood Pressure
Source: ClinicalTrials.gov NCT03056859 ↗
Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcomePrimary: Operator Satisfaction — 8 score on a scale
Summary
This is a single-arm observational trial of a device (Compass Vascular Access, Centurion Medical Products, Williamston MI). The device is a compact, sterile, single-use extravascular blood pressure transducer. This pressure measurement aids in confirmation of appropriate venous access. The investigators plan to enroll 40 consenting patients with BMI ≥35 who require central venous catheterization for clinical reasons independent of the existence of this study. The primary outcome is operator satisfaction.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Operator Satisfaction |
8 | — |
| SECONDARY Arterial Puncture Incidence |
— | — |
| SECONDARY Implement Used at Time of Arterial Puncture, if Any |
— | — |
Eligibility Criteria
Inclusion Criteria
- BMI ≥35
Exclusion Criteria
- Pregnant women
- Adults unable to consent
- Non-English speakers
- Prisoners
Data sourced from ClinicalTrials.gov (NCT03056859). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.